SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

AMERI Holdings, Inc. – ‘S-4’ on 5/27/20 – ‘EX-23.4’

On:  Wednesday, 5/27/20, at 5:49pm ET   ·   As of:  5/28/20   ·   Accession #:  1493152-20-9947   ·   File #:  333-238742

Previous ‘S-4’:  None   ·   Next:  ‘S-4/A’ on 8/12/20   ·   Latest:  ‘S-4/A’ on 8/4/21   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/28/20  AMERI Holdings, Inc.              S-4         5/27/20   98:16M                                    M2 Compliance/FA

Registration of Securities Issued in a Merger   —   Form S-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-4         Registration of Securities Issued in a              HTML   6.19M 
                Business-Combination Transaction                                 
 2: EX-2.4      Plan of Acquisition, Reorganization, Arrangement,   HTML     82K 
                Liquidation or Succession                                        
 3: EX-23.4     Consent of Experts or Counsel                       HTML     26K 
 4: EX-23.5     Consent of Experts or Counsel                       HTML     26K 
 5: EX-99.3     Miscellaneous Exhibit                               HTML     27K 
 6: EX-99.4     Miscellaneous Exhibit                               HTML     29K 
 7: EX-99.5     Miscellaneous Exhibit                               HTML     29K 
 8: EX-99.6     Miscellaneous Exhibit                               HTML     28K 
 9: EX-99.7     Miscellaneous Exhibit                               HTML     28K 
23: R1          Document and Entity Information                     HTML     39K 
68: R2          Condensed Consolidated Balance Sheets               HTML    146K 
81: R3          Condensed Consolidated Balance Sheets               HTML     46K 
                (Parenthetical)                                                  
50: R4          Condensed Consolidated Statements of Operations     HTML    163K 
                and Comprehensive Income (Loss)                                  
22: R5          Consolidated Statement of Changes in Stockholders'  HTML    119K 
                Equity                                                           
66: R6          Condensed Consolidated Statements of Cash Flows     HTML    115K 
79: R7          Description of Business                             HTML     36K 
52: R8          Summary of Significant Accounting Policies          HTML     61K 
20: R9          Basis of Presentation                               HTML     34K 
29: R10         Equity Transactions                                 HTML     51K 
40: R11         Business Combinations                               HTML     91K 
88: R12         Revenue Recognition                                 HTML     41K 
57: R13         Intangible Assets                                   HTML     42K 
28: R14         Goodwill                                            HTML     35K 
39: R15         Share-Based Compensation                            HTML     32K 
87: R16         Equity Compensation Plans                           HTML     59K 
56: R17         Warrants Outstanding                                HTML     45K 
30: R18         Earnings (Loss) Per Share                           HTML     52K 
38: R19         Incentive Plan Items                                HTML     29K 
86: R20         Bank Debt                                           HTML     32K 
75: R21         Debt                                                HTML     41K 
25: R22         Accrued Expenses and Other Current Liabilities      HTML     32K 
55: R23         Employee Benefit Plan                               HTML     28K 
85: R24         Income Taxes                                        HTML     43K 
74: R25         Convertible Notes                                   HTML     32K 
24: R26         Commitments and Contingencies                       HTML     40K 
54: R27         Fair Value Measurement                              HTML     50K 
84: R28         Preferred Stock                                     HTML     29K 
76: R29         Secured Note                                        HTML     29K 
59: R30         Subsequent Events                                   HTML     68K 
91: R31         Summary of Significant Accounting Policies          HTML    104K 
                (Policies)                                                       
36: R32         Business Combinations (Tables)                      HTML     58K 
26: R33         Earnings (Loss) Per Share (Tables)                  HTML     47K 
60: R34         Commitments and Contingencies (Tables)              HTML     35K 
92: R35         Warrants Outstanding (Tables)                       HTML     46K 
37: R36         Intangible Assets (Tables)                          HTML     41K 
27: R37         Goodwill (Tables)                                   HTML     32K 
58: R38         Equity Compensation Plans (Tables)                  HTML     58K 
93: R39         Debt (Tables)                                       HTML     32K 
69: R40         Accrued Expenses and Other Current Liabilities      HTML     32K 
                (Tables)                                                         
77: R41         Income Taxes (Tables)                               HTML     35K 
51: R42         Fair Value Measurement (Tables)                     HTML     44K 
19: R43         Description of Business (Details Narrative)         HTML     28K 
70: R44         Description of Business (Details Narrative) (10-K)  HTML     35K 
78: R45         Equity Transactions (Details Narrative) (10-K)      HTML    120K 
53: R46         Business Combinations (Details Narrative)           HTML     69K 
21: R47         Business Combinations (Details Narrative) (10-K)    HTML    117K 
67: R48         Business Combinations - Summary of Foregoing        HTML     83K 
                Acquisitions (Details)                                           
80: R49         Intangible Assets (Details Narrative)               HTML     30K 
96: R50         Intangible Assets (Details Narrative) (10-K)        HTML     35K 
62: R51         Intangible Assets - Schedule of Components of       HTML     37K 
                Intangible Assets (Details) (10-K)                               
35: R52         Intangible Assets - Schedule of Future              HTML     36K 
                Amortization of Intangible Assets (Details) (10-K)               
46: R53         Goodwill (Details Narrative)                        HTML     29K 
95: R54         Goodwill (Details Narrative) (10-K)                 HTML     29K 
61: R55         Goodwill - Schedule of Goodwill (Details) (10-K)    HTML     33K 
34: R56         Share-Based Compensation (Details Narrative)        HTML     35K 
                (10-K)                                                           
45: R57         Equity Compensation Plans (Details Narrative)       HTML     36K 
                (10-K)                                                           
94: R58         Equity Compensation Plans - Schedule of Option      HTML     71K 
                Activity (Details) (10-K)                                        
63: R59         Earnings (Loss) Per Share - Schedule of Earnings    HTML     68K 
                Per Share Basic and Diluted (Details)                            
17: R60         Incentive Plan Items (Details Narrative)            HTML     28K 
49: R61         Bank Debt (Details Narrative)                       HTML     44K 
83: R62         Debt (Details Narrative) (10-K)                     HTML     75K 
73: R63         Debt - Schedule of Short Term Debt (10-K)           HTML     35K 
                (Details)                                                        
16: R64         Accrued Expenses and Other Current Liabilities -    HTML     44K 
                Schedule of Accrued Expenses and Other Liabilities               
                (Details)                                                        
48: R65         Employee Benefit Plan (Details Narrative) (10-K)    HTML     33K 
82: R66         Income Taxes (Details Narrative) (10-K)             HTML     34K 
72: R67         Income Taxes - Schedule of Provision for Income     HTML     53K 
                Tax (10-K) (Details)                                             
18: R68         Convertible Notes (Details Narrative)               HTML     53K 
47: R69         Commitments and Contingencies (Details Narrative)   HTML     31K 
41: R70         Commitments and Contingencies - Schedule of         HTML     45K 
                Maturity Payments of Operating Leases (Details)                  
32: R71         Commitments and Contingencies (Details Narrative)   HTML     31K 
                (10-K)                                                           
64: R72         Commitments and Contingencies - Schedule of         HTML     45K 
                Maturity Payments of Operating Leases (Details)                  
                (10-K)                                                           
97: R73         Warrants Outstanding - Schedule of Warrants         HTML     42K 
                Activity (Details)                                               
43: R74         Warrants Outstanding - Schedule of Warrants         HTML     51K 
                Activity (Details) (10-K)                                        
33: R75         Preferred Stock (Details Narrative)                 HTML     37K 
65: R76         Secured Note (Details Narrative)                    HTML     32K 
98: R77         Fair Value Measurement - Schedule of Financial      HTML     38K 
                Assets Measured at Fair Value (10-K) (Details)                   
44: R78         Fair Value Measurement - Schedule of Fair Value     HTML     36K 
                Change in Levels (10-K) (Details)                                
31: R79         Subsequent Events (Details Narrative)               HTML     55K 
42: R80         Subsequent Events (Details Narrative) (10-K)        HTML     67K 
89: XML         IDEA XML File -- Filing Summary                      XML    173K 
71: EXCEL       IDEA Workbook of Financial Reports                  XLSX    103K 
10: EX-101.INS  XBRL Instance -- amrh-20200331                       XML   1.62M 
12: EX-101.CAL  XBRL Calculations -- amrh-20200331_cal               XML    195K 
13: EX-101.DEF  XBRL Definitions -- amrh-20200331_def                XML    561K 
14: EX-101.LAB  XBRL Labels -- amrh-20200331_lab                     XML   1.05M 
15: EX-101.PRE  XBRL Presentations -- amrh-20200331_pre              XML    846K 
11: EX-101.SCH  XBRL Schema -- amrh-20200331                         XSD    203K 
90: ZIP         XBRL Zipped Folder -- 0001493152-20-009947-xbrl      Zip    158K 


‘EX-23.4’   —   Consent of Experts or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 23.4

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Ameri Holdings, Inc.

Suwanee, Georgia

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-4 of our report dated March 25, 2020, relating to the audited condensed consolidated financial statements of Ameri Holdings, Inc. appearing in the Annual Report on Form 10-K of Ameri Holdings, Inc. for the year ended December 31, 2019, and to the reference to us under the heading “Experts” in the Prospectus, which is part of this Registration Statement.

 

/s/ Ram Associates

Hamilton, NJ

 

May 27, 2020

 

 C: 
   

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-4’ Filing    Date    Other Filings
Filed as of:5/28/20
Filed on:5/27/20
3/25/2010-K
12/31/1910-K,  10-K/A
 List all Filings 


8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/21  Enveric Biosciences, Inc.         S-3         2/17/21    4:545K                                   M2 Compliance LLC/FA
 1/13/21  Enveric Biosciences, Inc.         424B5                  1:800K                                   M2 Compliance LLC/FA
12/28/20  Enveric Biosciences, Inc.         S-4MEF     12/28/20    8:810K                                   M2 Compliance LLC/FA
11/10/20  Enveric Biosciences, Inc.         S-4/A                121:18M                                    M2 Compliance LLC/FA
11/09/20  Enveric Biosciences, Inc.         S-4/A                122:18M                                    M2 Compliance LLC/FA
10/22/20  Enveric Biosciences, Inc.         S-4/A                123:18M                                    M2 Compliance LLC/FA
 9/17/20  Enveric Biosciences, Inc.         S-4/A       9/16/20  118:18M                                    M2 Compliance LLC/FA
 8/12/20  Enveric Biosciences, Inc.         S-4/A                113:17M                                    M2 Compliance LLC/FA
Top
Filing Submission 0001493152-20-009947   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 10:12:17.2am ET